Código QR (código de barras bidimensional)

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial

Abstract Background Mineralocorticoid receptor antagonists (MRAs) are often underutilized in patients with heart failure (HF), particularly those with diabetes and/or chronic kidney disease (CKD). However, the impact of concurrent diabetes and CKD on the efficacy and safety of eplerenone in acute HF...

Fuld beskrivelse

Na minha lista:
Principais autores: Masatake Kobayashi, Akira Yamashina, Kazuhiro Satomi, Masataka Watanabe, Ryu Takagi, Ayako Tezuka, Shin Ito, Masanori Asakura, Masafumi Kitakaze
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-03-01
Serier:Cardiovascular Diabetology
Fag:
Acute heart failure
Eplerenone
Mineralocorticoid receptor antagonist
Diabetes
Chronic kidney disease
Prognosis
Online adgang:https://doi.org/10.1186/s12933-025-02659-y
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker